Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-24

Clinical Trial Update: Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients [Phase 4]

View source ↗

Summary

This Phase 4 open-label interventional trial assessed the efficacy and safety of an extemporaneously combined nebivolol and ramipril regimen in hypertensive pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)
  • Ramipril (ramipril)

Snippet

Sponsor: Menarini International Operations Luxembourg SA | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2025-04-24